Maple Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-07-2024
- Paid Up Capital ₹ 2.00 M
as on 16-07-2024
- Company Age 42 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.06 Cr
as on 16-07-2024
- Satisfied Charges ₹ 1.35 M
as on 16-07-2024
- Revenue 51.10%
(FY 2023)
- Profit 15.53%
(FY 2023)
- Ebitda 32.46%
(FY 2023)
- Net Worth 16.96%
(FY 2023)
- Total Assets 10.82%
(FY 2023)
About Maple Biotech
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 2.00 M.
The company currently has active open charges totaling ₹8.06 Cr. The company has closed loans amounting to ₹1.35 M, as per Ministry of Corporate Affairs (MCA) records.
Sujata Bhandari, Nandan Bhandari, and Pratik Bhandari serve as directors at the Company.
- CIN/LLPIN
U24117PN1982PTC028838
- Company No.
028838
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Dec 1982
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Maple Biotech Pvt Ltd offer?
Maple Biotech Pvt Ltd offers a wide range of products and services, including Child and Baby Care Products, Diaper, Industrial Chemicals & Supplies, Agro Chemicals, Pharma Ingredients & Raw Materials, Pharmaceutical Excipients, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Ice Cream Raw Materials, Ice Cream Stabiliser.
Who are the key members and board of directors at Maple Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandan Bhandari  | Managing Director | 05-Dec-1982 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sujata Bhandari | Whole-Time Director | 05-May-1992 | Current |
| Pratik Bhandari | Whole-Time Director | 01-Sep-2014 | Current |
Financial Performance of Maple Biotech.
Maple Biotech Pvt Ltd, for the financial year ended 2023, experienced significant growth in revenue, with a 51.1% increase. The company also saw a substantial improvement in profitability, with a 15.53% increase in profit. The company's net worth Soared by an impressive increase of 16.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maple Biotech?
In 2023, Maple Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Nov 2023 | ₹1.50 Cr | Open |
Others Creation Date: 16 Jun 2023 | ₹1.20 Cr | Open |
Others Creation Date: 24 Feb 2021 | ₹1.81 M | Open |
How Many Employees Work at Maple Biotech?
Maple Biotech has a workforce of 19 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maple Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maple Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
